Log in to save to my catalogue

Supplementation of Creatine Monohydrate Improves Sprint Performance but Has no Effect on Glycolytic...

Supplementation of Creatine Monohydrate Improves Sprint Performance but Has no Effect on Glycolytic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8251e1f17051494ab3bea33615e95f7d

Supplementation of Creatine Monohydrate Improves Sprint Performance but Has no Effect on Glycolytic Contribution: A Nonrandomized, Placebo-Controlled Crossover Trial in Trained Cyclists Supplementation of Creatine Monohydrate Improves Sprint Performance but Has no Effect on Glycolytic Contribution: A Nonrandomized, Placebo-Controlled Crossover Trial in Trained Cyclists

About this item

Full title

Supplementation of Creatine Monohydrate Improves Sprint Performance but Has no Effect on Glycolytic Contribution: A Nonrandomized, Placebo-Controlled Crossover Trial in Trained Cyclists Supplementation of Creatine Monohydrate Improves Sprint Performance but Has no Effect on Glycolytic Contribution: A Nonrandomized, Placebo-Controlled Crossover Trial in Trained Cyclists

Publisher

Elsevier

Journal title

Current developments in nutrition, 2025-02, Vol.9 (2), p.104561

Language

English

Formats

Publication information

Publisher

Elsevier

More information

Scope and Contents

Contents

Background: Sprint performance may be crucial for athletes in sprint and endurance sports. In this regard, the maximal glycolytic rate (νLamax) is a variable within Mader’s model of metabolism that is commonly tested in a 15-s all-out sprint test. The product of lactate accumulation (ΔLa) and lactate distribution space approximated by fat-free mass...

Alternative Titles

Full title

Supplementation of Creatine Monohydrate Improves Sprint Performance but Has no Effect on Glycolytic Contribution: A Nonrandomized, Placebo-Controlled Crossover Trial in Trained Cyclists Supplementation of Creatine Monohydrate Improves Sprint Performance but Has no Effect on Glycolytic Contribution: A Nonrandomized, Placebo-Controlled Crossover Tria...

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8251e1f17051494ab3bea33615e95f7d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8251e1f17051494ab3bea33615e95f7d

Other Identifiers

E-ISSN

2475-2991

How to access this item